000300250 001__ 300250
000300250 005__ 20250821115050.0
000300250 0247_ $$2pmid$$apmid:40180755
000300250 0247_ $$2ISSN$$a2509-4262
000300250 0247_ $$2ISSN$$a2509-4254
000300250 0247_ $$2doi$$a10.1007/s41669-025-00568-0
000300250 037__ $$aDKFZ-2025-00711
000300250 041__ $$aEnglish
000300250 082__ $$a610
000300250 1001_ $$0P:(DE-He78)e87b1ce9c94af84cffcf9279cece3738$$aPham, Phu Duy$$b0$$eFirst author
000300250 245__ $$aMeasuring the Socioeconomic Impact of Cancer: A Systematic Review and Standardized Assessment of Patient-Reported Outcomes (PRO) Instruments.
000300250 260__ $$a[Cham]$$bSpringer International Publishing$$c2025
000300250 3367_ $$2DRIVER$$aarticle
000300250 3367_ $$2DataCite$$aOutput Types/Journal article
000300250 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1753776774_3431$$xReview Article
000300250 3367_ $$2BibTeX$$aARTICLE
000300250 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000300250 3367_ $$00$$2EndNote$$aJournal Article
000300250 500__ $$a#EA:C100#LA:C100# / 2025 Jul;9(4):519-539
000300250 520__ $$aA number of instruments have been developed to measure the socioeconomic impact (SEI) of cancer. A standardized comparison of the quality and content validity of these instruments is lacking. This study aimed to (1) conduct a standardized assessment of the quality of SEI instruments and (2) assess the content validity of these instruments using the conceptual framework developed by the Organization of European Cancer Institutes (OECI) for SEI analysis.We identified articles measuring the SEI of cancer with ad hoc and/or validated instruments from an existing database. These articles were the initial pearls in a systematic review of published articles that applied and validated these instruments using the pearl-growing search strategy in PubMed, Web of Science, and Google Scholar databases. The Evaluating the Measurement of Patient-Reported Outcomes (EMPRO) tool was utilized to provide quantitative assessment and comparison of the quality of identified instruments. To examine content validity, we allocated each instrument's items against the themes and sub-themes of the established conceptual framework for SEI analysis.We identified and investigated 21 validation studies using nine original instruments. The number of articles varied significantly among the identified instruments. The COmprehensive Score for financial Toxicity (COST) instrument was the most frequently used, validated in ten different settings, whereas some newer instruments have not been applied yet. This variation resulted in significant differences in EMPRO overall scores among these instruments. Regarding content validity, we found that not all themes of the OECI framework were covered by the content of the instruments.The quality and the application of instruments measuring the SEI of cancer varied significantly. The content of the instruments seems not to cover all related themes of the applied OECI framework in this study. Further studies are warranted to confirm the quality and content validity of the instruments measuring the SEI of cancer.
000300250 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000300250 588__ $$aDataset connected to DataCite, PubMed, , Journals: inrepo02.dkfz.de
000300250 7001_ $$0P:(DE-He78)7586e13ade56c5b4d4cba2fc411b0cf0$$aUbels, Jasper$$b1$$udkfz
000300250 7001_ $$0P:(DE-He78)9600624b0539f0fa9344e8936954b93d$$aEckford, Rachel$$b2$$udkfz
000300250 7001_ $$0P:(DE-He78)1f315d09721b91091df1ba78eb65cbaf$$aSchlander, Michael$$b3$$eLast author$$udkfz
000300250 773__ $$0PERI:(DE-600)2874287-4$$aDOI:10.1007/s41669-025-00568-0$$n4$$p519-539$$tPharmacoEconomics - open$$v9$$x2509-4262$$y2025
000300250 909CO $$ooai:inrepo02.dkfz.de:300250$$pVDB
000300250 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPHARMACOECON-OPEN : 2022$$d2024-12-16
000300250 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-16
000300250 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-16
000300250 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-16
000300250 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2024-12-16
000300250 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-16
000300250 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:44:09Z
000300250 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:44:09Z
000300250 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-10T15:44:09Z
000300250 915__ $$0LIC:(DE-HGF)CCBYNCNV$$2V:(DE-HGF)$$aCreative Commons Attribution-NonCommercial CC BY-NC (No Version)$$bDOAJ$$d2024-04-10T15:44:09Z
000300250 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-16
000300250 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-16
000300250 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-16
000300250 9141_ $$y2025
000300250 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e87b1ce9c94af84cffcf9279cece3738$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000300250 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7586e13ade56c5b4d4cba2fc411b0cf0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000300250 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9600624b0539f0fa9344e8936954b93d$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000300250 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1f315d09721b91091df1ba78eb65cbaf$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000300250 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000300250 9202_ $$0I:(DE-He78)C100-20160331$$kC100$$lGesundheitsökonomie$$x0
000300250 9201_ $$0I:(DE-He78)C100-20160331$$kC100$$lGesundheitsökonomie$$x0
000300250 9200_ $$0I:(DE-He78)C100-20160331$$kC100$$lGesundheitsökonomie$$x0
000300250 980__ $$ajournal
000300250 980__ $$aVDB
000300250 980__ $$aI:(DE-He78)C100-20160331
000300250 980__ $$aUNRESTRICTED